PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,764,932 | -37.0% | 435,740 | +14.3% | 0.00% | -50.0% |
| Q2 2023 | $15,498,361 | +41.6% | 381,076 | +68.7% | 0.00% | +100.0% |
| Q1 2023 | $10,942,111 | -3.7% | 225,890 | -24.1% | 0.00% | 0.0% |
| Q4 2022 | $11,361,873 | -20.4% | 297,665 | +4.7% | 0.00% | -50.0% |
| Q3 2022 | $14,270,000 | -16.1% | 284,249 | -33.0% | 0.00% | 0.0% |
| Q2 2022 | $17,001,000 | +32.6% | 424,387 | +23.5% | 0.00% | 0.0% |
| Q1 2022 | $12,817,000 | +49.2% | 343,534 | +59.3% | 0.00% | +100.0% |
| Q4 2021 | $8,592,000 | +450.4% | 215,715 | +414.2% | 0.00% | – |
| Q3 2021 | $1,561,000 | -79.4% | 41,950 | -76.6% | 0.00% | -100.0% |
| Q2 2021 | $7,588,000 | +757.4% | 179,481 | +859.6% | 0.00% | – |
| Q1 2021 | $885,000 | -72.0% | 18,703 | -63.9% | 0.00% | – |
| Q4 2020 | $3,165,000 | +241.4% | 51,876 | +161.3% | 0.00% | – |
| Q3 2020 | $927,000 | -35.5% | 19,854 | -29.9% | 0.00% | – |
| Q2 2020 | $1,438,000 | -62.5% | 28,338 | -67.0% | 0.00% | -100.0% |
| Q1 2020 | $3,830,000 | -71.2% | 85,872 | -69.0% | 0.00% | -66.7% |
| Q4 2019 | $13,300,000 | +552.6% | 276,931 | +359.5% | 0.00% | +200.0% |
| Q3 2019 | $2,038,000 | +13.4% | 60,266 | +50.9% | 0.00% | – |
| Q2 2019 | $1,797,000 | +90.8% | 39,930 | +59.6% | 0.00% | – |
| Q1 2019 | $942,000 | -72.3% | 25,011 | -74.8% | 0.00% | -100.0% |
| Q4 2018 | $3,402,000 | -57.8% | 99,137 | -42.2% | 0.00% | -50.0% |
| Q3 2018 | $8,058,000 | -58.5% | 171,446 | -70.2% | 0.00% | -60.0% |
| Q2 2018 | $19,401,000 | +17.2% | 575,189 | -6.0% | 0.01% | 0.0% |
| Q1 2018 | $16,553,000 | +646.0% | 611,722 | +359.8% | 0.01% | +400.0% |
| Q4 2017 | $2,219,000 | +6.9% | 133,047 | +28.3% | 0.00% | 0.0% |
| Q3 2017 | $2,075,000 | -80.4% | 103,690 | -82.0% | 0.00% | -66.7% |
| Q2 2017 | $10,574,000 | +612.5% | 576,857 | +282.9% | 0.00% | – |
| Q1 2017 | $1,484,000 | -76.9% | 150,646 | -74.5% | 0.00% | -100.0% |
| Q4 2016 | $6,438,000 | +1356.6% | 590,206 | +1768.2% | 0.00% | – |
| Q3 2016 | $442,000 | +192.7% | 31,593 | +46.9% | 0.00% | – |
| Q2 2016 | $151,000 | +109.7% | 21,508 | +94.0% | 0.00% | – |
| Q1 2016 | $72,000 | -59.6% | 11,089 | +101.2% | 0.00% | – |
| Q4 2015 | $178,000 | -89.8% | 5,511 | -91.6% | 0.00% | -100.0% |
| Q3 2015 | $1,746,000 | +19.5% | 65,373 | +115.4% | 0.00% | 0.0% |
| Q2 2015 | $1,461,000 | +68.7% | 30,346 | +113.3% | 0.00% | – |
| Q1 2015 | $866,000 | -2.4% | 14,230 | -16.9% | 0.00% | – |
| Q4 2014 | $887,000 | +77.8% | 17,129 | +51.1% | 0.00% | – |
| Q3 2014 | $499,000 | +16.0% | 11,338 | -30.9% | 0.00% | – |
| Q2 2014 | $430,000 | +29.9% | 16,417 | +29.7% | 0.00% | – |
| Q1 2014 | $331,000 | +190.4% | 12,654 | +89.0% | 0.00% | – |
| Q4 2013 | $114,000 | – | 6,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |